First Trust NYSE Arca Biotechnology Index Fund
270 hedge funds and large institutions have $580M invested in First Trust NYSE Arca Biotechnology Index Fund in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 80 increasing their positions, 84 reducing their positions, and 14 closing their positions.
6,906% more call options, than puts
Call options by funds: $2.38M | Put options by funds: $34K
129% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 14
5% more funds holding
Funds holding: 256 → 270 (+14)
1.06% more ownership
Funds ownership: 51.4% → 52.46% (+1.1%)
2% more capital invested
Capital invested by funds: $569M → $580M (+$10.9M)
5% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 84
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFGP
Stonebridge Financial Group (Pennsylvania)
Wormleysburg,
Pennsylvania
|
+$13.3M |
| 2 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$7.52M |
| 3 |
Two Sigma Investments
New York
|
+$5.33M |
| 4 |
RIA
RPG Investment Advisory
Pleasanton,
California
|
+$4.49M |
| 5 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$2.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$11.1M |
| 2 |
BFG
Berger Financial Group
Plymouth,
Minnesota
|
-$7.52M |
| 3 |
LJAC
L.J. Altfest & Co
New York
|
-$5.02M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4.43M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.37M |
FBT Hedge Fund Activity: Q1 2025 in Review
270 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2025, worth a combined $580M — up 1.9% from $569M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new FBT positions and 14 closed out — a net gain of 18 holders — while 80 added to existing stakes and 84 trimmed.
The largest buyer was Stonebridge Financial Group (Pennsylvania), opening a new position worth an estimated $13.3M. The largest seller was Morgan Stanley, cutting an estimated $11.1M.
- 270 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2025, up from 256 in Q4 2024.
- Funds reported $580M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2025, up 1.9% quarter-over-quarter.
- 32 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2025 and 14 closed out, a net change of +18 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2025 was Stonebridge Financial Group (Pennsylvania), an estimated $13.3M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2025 was Morgan Stanley, an estimated $11.1M sold.
Based on aggregated 13F filings for Q1 2025.